China (Mainland)
top quality sell 30123-17-2 high purity tianeptine acid CAS NO.30123-17-2
- FOB Price: USD: 1.00-1.00 /Metric Ton Get Latest Price
- Min.Order: 100 Gram
- Payment Terms: L/C,D/A,D/P,T/T,
- Available Specifications:
0(1-100)Metric Ton
- Product Details
Keywords
- sell 30123-17-2
- high purity tianeptine acid
- top quality tianeptine acid
Quick Details
- ProName: top quality sell 30123-17-2 high purit...
- CasNo: 30123-17-2
- Molecular Formula: C21H24ClN2NaO4S
- Appearance: White fine powder
- Application: in the treatment of major depressive ...
- DeliveryTime: Within 2 days
- PackAge: 100g/bag or according to the buyers' r...
- Port: Qingdao Port
- ProductionCapacity: 3000 Kilogram/Month
- Purity: 99.5%
- Storage: Cool and dry
- Transportation: EMS、TNT、DHL、UPS、FEDEX
- LimitNum: 100 Gram
- Related Substances: See detailed descrition
- Residue on Ignition: NMT 0.2%
- Heavy Metal: NA
- Valid Period: 2 years
- MW: 458.93
Superiority
top quality sell 30123-17-2 high purity tianeptine acid
1.Reasonable price:
We provide high quality products with competitive price in china,
2.Low moq:
No worry about the low moq, our moq is 1 gram or lower.
3.Good and efficient service,Fast Delivery
Fast respond save client's time, we promise to reply inquiry in 24 hours including holidays and send quotation sheet and other documents in 48 hours.
4.Super-good quality
We have strict quality control system .Good reputation in Market
Contact us
If you have any further questions or need a sample,Please do not hesitate to contact us.
Details
1.Tianeptine Sodium
2.Specification: 99%
3.CAS 30123-17-2
4.Appearance:White crystalline powder
5.GMP BV SGS ISO
Description of Tianeptine Sodium
Tianeptine is a drug used primarily in the treatment of major depressive disorder, although it may also be used to treat asthma or irritable bowel syndrome. Chemically it is a tricyclic antidepressant (TCA), but it has different pharmacological properties than typical TCAs as recent research suggests that tianeptine produces its antidepressant effects through indirect alteration of glutamate receptor activity (i.e., AMPA receptors and NMDA receptors) and release of BDNF, in turn affecting neural plasticity.
